NOVOMEDLINK™
  1. Diabetes Care

    GlucaGen® HypoKit®

    (glucagon [rDNA Origin] for injection)

  2. Levemir®

    (insulin detemir [rDNA origin] injection)

  3. NovoLog®

    (Insulin aspart [rDNA origin] injection)

  4. NovoLog® Mix 70/30

    (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

  5. Victoza®

    (liraglutide [rDNA origin] injection)

  6. Hormone Therapy

    Activella®

    (estradiol/norethindrone acetate tablets)

  7. Vagifem®

    (estradiol vaginal tablets)

  8. Growth Hormone

    Norditropin®

    (somatropin (rDNA origin) injection)

  9. Hemostasis

    NovoSeven®

    (Coagulation Factor VIIa [Recombinant])

  10. NovoSeven® RT

    Coagulation Factor VIIa (Recombinant) Room
    Temperature Stable

diabetes resources & tools

Your one-stop diabetes online resource

NovoMedLink™ is an online resource for health care professionals seeking diabetes treatment information, with additional content added on a regular basis.

  1. educational podcasts
    educational podcasts

    Podcasts are available for download to provide clinical information about Novo Nordisk products for the treatment of diabetes.

  2. eNewsletters
    eNewsletters

    Monthly eNewsletters covering the latest developments in diabetes care.

  3. links
    links

    Links to organizations and journals involved in the study and treatment of diabetes.

  4. formulary tool
    formulary tool

    Determine drug coverage for health plans in your area.

  5. slides & reprints
    slides & reprints

    Download slides and reprints that present detailed product information, including indications, safety, studies, and more.

FlexPen®, GlucaGen®, HypoKit®, Levemir®, NovoFine®, and NovoLog® are registered trademarks and NovoMedLink™ is a trademark of Novo Nordisk A/S. Norditropin® and NovoSeven® are registered trademarks of Novo Nordisk Health Care AG. Activella® and Vagifem® are registered trademarks of Novo Nordisk FemCare AG.